Text of IN HB 1231 (2023)
Gender transition procedures for minors.
Legislative text is a public record. Where LegiScan supplied it, the CC BY 4.0 credit applies.
Source: LegiScan. Bill data and text from LegiScan (legiscan.com), licensed CC BY 4.0 and used in modified form. LegiScan does not endorse the Trans Data Initiative. License: CC BY 4.0(opens another site). Source page(opens another site)
As introduced
18,138 characters
Introduced Version
HOUSE BILL No. 1231
_____
DIGEST OF INTRODUCED BILL
Citations Affected: IC 12-15-1-23; IC 16-18-2; IC 16-35-12;
IC 27-2-28; IC 34-18-1-1.
Synopsis: Gender transition procedures for minors. Prohibits specified
health care professionals from providing gender transition procedures
to a minor that are intended to alter the gender of the minor or delay
puberty. Provides for certain medical exceptions. Prohibits public
funds, Medicaid, or a health carrier from providing reimbursement or
coverage for gender transition procedures to a minor. Creates a civil
cause of action. Makes conforming changes.
Effective: July 1, 2023.
Lauer
January 10, 2023, read first time and referred to Committee on Public Health.
2023
IN 1231—LS 7276/DI 147
Introduced
First Regular Session of the 123rd General Assembly (2023)
PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana
Constitution) is being amended, the text of the existing provision will appear in this style type,
additions will appear in this style type, and deletions will appear in this style type.
Additions: Whenever a new statutory provision is being enacted (or a new constitutional
provision adopted), the text of the new provision will appear in this style type. Also, the
word NEW will appear in that style type in the introductory clause of each SECTION that adds
a new provision to the Indiana Code or the Indiana Constitution.
Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts
between statutes enacted by the 2022 Regular Session of the General Assembly.
HOUSE BILL No. 1231
A BILL FOR AN ACT to amend the Indiana Code concerning
health.
Be it enacted by the General Assembly of the State of Indiana:
1
SECTION 1. IC 12-15-1-23 IS ADDED TO THE INDIANA CODE
2
AS A NEW SECTION TO READ AS FOLLOWS [EFFECTIVE JULY
3
1, 2023]: Sec. 23. The office may not use federal or state funds
4
under the Medicaid program to pay or provide coverage for
5
gender transition procedures (as defined by IC 16-35-12-6) to an
6
individual who is less than eighteen (18) years of age.
7
SECTION 2. IC 16-18-2-36.1 IS ADDED TO THE INDIANA
8
CODE AS A NEW SECTION TO READ AS FOLLOWS
9
[EFFECTIVE JULY 1, 2023]: Sec. 36.1. "Biological sex", for
10
purposes of IC 16-35-12, has the meaning set forth in
11
IC 16-35-12-1.
12
SECTION 3. IC 16-18-2-88.7 IS ADDED TO THE INDIANA
13
CODE AS A NEW SECTION TO READ AS FOLLOWS
14
[EFFECTIVE JULY 1, 2023]: Sec. 88.7. "Cross sex hormones", for
15
purposes of IC 16-35-12, has the meaning set forth in
16
IC 16-35-12-2.
17
SECTION 4. IC 16-18-2-144.2 IS ADDED TO THE INDIANA
2023
IN 1231—LS 7276/DI 147
2
1
CODE AS A NEW SECTION TO READ AS FOLLOWS
2
[EFFECTIVE JULY 1, 2023]: Sec. 144.2. "Gender", for purposes of
3
IC 16-35-12, has the meaning set forth in IC 16-35-12-3.
4
SECTION 5. IC 16-18-2-144.3 IS ADDED TO THE INDIANA
5
CODE AS A NEW SECTION TO READ AS FOLLOWS
6
[EFFECTIVE JULY 1, 2023]: Sec. 144.3. "Gender reassignment
7
surgery", for purposes of IC 16-35-12, has the meaning set forth in
8
IC 16-35-12-4.
9
SECTION 6. IC 16-18-2-144.4 IS ADDED TO THE INDIANA
10
CODE AS A NEW SECTION TO READ AS FOLLOWS
11
[EFFECTIVE JULY 1, 2023]: Sec. 144.4. "Gender transition", for
12
purposes of IC 16-35-12, has the meaning set forth in
13
IC 16-35-12-5.
14
SECTION 7. IC 16-18-2-144.5 IS ADDED TO THE INDIANA
15
CODE AS A NEW SECTION TO READ AS FOLLOWS
16
[EFFECTIVE JULY 1, 2023]: Sec. 144.5. "Gender transition
17
procedures", for purposes of IC 16-35-12, has the meaning set
18
forth in IC 16-35-12-6.
19
SECTION 8. IC 16-18-2-148.2 IS ADDED TO THE INDIANA
20
CODE AS A NEW SECTION TO READ AS FOLLOWS
21
[EFFECTIVE JULY 1, 2023]: Sec. 148.2. "Genital gender
22
reassignment surgery", for purposes of IC 16-35-12, has the
23
meaning set forth in IC 16-35-12-7.
24
SECTION 9. IC 16-18-2-157.2 IS ADDED TO THE INDIANA
25
CODE AS A NEW SECTION TO READ AS FOLLOWS
26
[EFFECTIVE JULY 1, 2023]: Sec. 157.2. "Harm", for purposes of
27
IC 16-35-12, has the meaning set forth in IC 16-35-12-8.
28
SECTION 10. IC 16-18-2-162, AS AMENDED BY P.L.212-2005,
29
SECTION 5, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
30
JULY 1, 2023]: Sec. 162. (a) "Health care professional", for purposes
31
of IC 16-27-1 and IC 16-27-4, has the meaning set forth in
32
IC 16-27-1-1.
33
(b) "Health care professional", for purposes of IC 16-27-2, has the
34
meaning set forth in IC 16-27-2-1.
35
(c) "Health care professional", for purposes of IC 16-35-12, has
36
the meaning set forth in IC 16-35-12-9.
37
SECTION 11. IC 16-18-2-250.5 IS ADDED TO THE INDIANA
38
CODE AS A NEW SECTION TO READ AS FOLLOWS
39
[EFFECTIVE JULY 1, 2023]: Sec. 250.5. "Nongenital gender
40
reassignment surgery", for purposes of IC 16-35-12, has the
41
meaning set forth in IC 16-35-12-11.
42
SECTION 12. IC 16-18-2-296.7 IS ADDED TO THE INDIANA
2023
IN 1231—LS 7276/DI 147
3
1
CODE AS A NEW SECTION TO READ AS FOLLOWS
2
[EFFECTIVE JULY 1, 2023]: Sec. 296.7. "Puberty blocking drugs",
3
for purposes of IC 16-35-12, has the meaning set forth in
4
IC 16-35-12-12.
5
SECTION 13. IC 16-18-2-297.2 IS ADDED TO THE INDIANA
6
CODE AS A NEW SECTION TO READ AS FOLLOWS
7
[EFFECTIVE JULY 1, 2023]: Sec. 297.2. "Public funds", for
8
purposes of IC 16-35-12, has the meaning set forth in
9
IC 16-35-12-13.
10
SECTION 14. IC 16-35-12 IS ADDED TO THE INDIANA CODE
11
AS A NEW CHAPTER TO READ AS FOLLOWS [EFFECTIVE
12
JULY 1, 2023]:
13
Chapter 12. Gender Transition Procedures for Minors
14
Sec. 1. As used in this chapter, "biological sex" means the
15
biological indication of male and female in the context of
16
reproductive potential or capacity, including sex chromosomes,
17
naturally occurring sex hormones, gonads, and nonambiguous
18
internal and external genitalia present at birth, without regard to
19
an individual's psychological, chosen, or subjective experience of
20
gender.
21
Sec. 2. As used in this chapter, "cross sex hormones" means the
22
following:
23
(1) Testosterone or other androgens given to biological sex
24
females in amounts that are larger or more potent than would
25
normally occur naturally in healthy biological sex females.
26
(2) Estrogen given to biological sex males in amounts that are
27
larger or more potent than would normally occur naturally in
28
healthy biological sex males.
29
Sec. 3. As used in this chapter, "gender" means the
30
psychological, behavioral, social, and cultural aspects of being male
31
or female.
32
Sec. 4. As used in this chapter, "gender reassignment surgery"
33
means any medical or surgical service that seeks to surgically alter
34
or remove healthy physical or anatomical characteristics or
35
features that are typical for the individual's biological sex, in order
36
to instill or create physiological or anatomical characteristics that
37
resemble a sex different from the individual's biological sex,
38
including genital gender reassignment surgery or nongenital
39
gender reassignment surgery performed for the purpose of
40
assisting an individual with a gender transition.
41
Sec. 5. As used in this chapter, "gender transition" means the
42
process in which an individual shifts from identifying with and
2023
IN 1231—LS 7276/DI 147
4
1
living as a gender that corresponds to his or her biological sex to
2
identifying with and living as a gender different from his or her
3
biological sex, and may involve social, legal, or physical changes.
4
Sec. 6. (a) As used in this chapter, "gender transition
5
procedures" means any medical or surgical service, including
6
physician's services, inpatient and outpatient hospital services, or
7
prescribed drugs related to gender transition that seeks to:
8
(1) alter or remove physical or anatomical characteristics or
9
features that are typical for the individual's biological sex; or
10
(2) instill or create physiological or anatomical characteristics
11
that resemble a sex different from the individual's biological
12
sex, including medical services that provide puberty blocking
13
drugs, cross sex hormones, or other mechanisms to promote
14
the development of feminizing or masculinizing features in the
15
opposite biological sex, or genital gender reassignment
16
surgery or nongenital gender reassignment surgery
17
performed for the purpose of assisting an individual with a
18
gender transition.
19
(b) The term does not include the following:
20
(1) Services to an individual born with a medically verifiable
21
disorder of sex development, including an individual with:
22
(A) external biological sex characteristics that are
23
irresolvably ambiguous;
24
(B) forty-six (46) XX chromosomes with virilization;
25
(C) forty-six (46) XY chromosomes with undervirilization;
26
or
27
(D) both ovarian and testicular tissue.
28
(2) Services provided when a physician has diagnosed a
29
disorder of sexual development that the physician has
30
determined through genetic or biochemical testing that the
31
individual does not have normal sex chromosome structure,
32
sex steroid hormone production, or sex steroid hormone
33
action.
34
(3) The treatment of any infection, injury, disease, or disorder
35
that has been caused by or exacerbated by the performance of
36
gender transition procedures.
37
(4) Any procedure undertaken because the individual suffers
38
from a physical disorder, physical injury, or physical illness
39
that would, as certified by a physician, place the individual in
40
imminent danger of death or impairment of major bodily
41
function unless surgery is performed.
42
Sec. 7. As used in this chapter, "genital gender reassignment
2023
IN 1231—LS 7276/DI 147
5
1
surgery" means a medical procedure performed for the purpose of
2
assisting an individual with a gender transition, including the
3
following:
4
(1) Surgical procedures, including a penectomy, orchiectomy,
5
vaginoplasty, clitoroplasty, or vulvoplasty for biological sex
6
male patients or hysterectomy or ovariectomy for biological
7
sex female patients.
8
(2) Reconstruction of the fixed part of the urethra with or
9
without a metoidioplasty.
10
(3) Phalloplasty, vaginectomy, scrotoplasty, or implantation
11
of erection or testicular prostheses for biological sex female
12
patients.
13
Sec. 8. As used in this chapter, "harm" includes the following:
14
(1) Physical injury.
15
(2) Psychological harm or impairment.
16
(3) Emotional distress.
17
Sec. 9. As used in this chapter, "health care professional" refers
18
to the following:
19
(1) A physician licensed under IC 25-22.5.
20
(2) A nurse, including an advanced practice registered nurse,
21
licensed under IC 25-23.
22
(3) Any of the behavioral health or human services
23
professionals licensed under IC 25-23.6.
24
(4) A physician assistant licensed under IC 25-27.5.
25
(5) A psychologist licensed under IC 25-33.
26
Sec. 10. As used in this chapter, "minor" means an individual
27
who is less than eighteen (18) years of age.
28
Sec. 11. As used in this chapter, "nongenital gender
29
reassignment surgery" means medical procedures performed for
30
the purpose of assisting an individual with a gender transition,
31
including the following:
32
(1) Surgical procedures for biological sex male patients,
33
including augmentation mammoplasty, facial feminization
34
surgery, liposuction, lipofilling, voice surgery, thyroid
35
cartilage reduction, gluteal augmentation, hair
36
reconstruction, or associated aesthetic procedures.
37
(2) Surgical procedures for biological sex female patients,
38
including subcutaneous mastectomy, voice surgery,
39
liposuction, lipofilling, pectoral implants, or associated
40
aesthetic procedures.
41
Sec. 12. As used in this chapter, "puberty blocking drugs"
42
means:
2023
IN 1231—LS 7276/DI 147
6
1
(1) gonadotropin releasing hormone analogs or other
2
synthetic drugs used in biological sex males to stop luteinizing
3
hormone secretion and testosterone secretion; or
4
(2) synthetic drugs used in biological sex females that stop the
5
production of estrogens and progesterone;
6
when used to delay or suppress pubertal development in a minor
7
for the purpose of assisting an individual with a gender transition.
8
Sec. 13. As used in this chapter, "public funds" means state,
9
county, or local government funds, in addition to any department,
10
agency, or instrumentality authorized or appropriated funds under
11
state law or derived from any fund in which the funds are
12
deposited.
13
Sec. 14. (a) Except as provided in subsection (c), a health care
14
professional may not provide gender transition procedures to a
15
minor.
16
(b) Except as provided in subsection (c), a health care
17
professional may not refer a minor to any practitioner for gender
18
transition procedures.
19
(c) This section does not prohibit a health care professional from
20
providing any of the following procedures to a minor:
21
(1) Services to individuals born with a medically verifiable
22
disorder of sex development, including individuals having:
23
(A) both ovarian and testicular tissue; or
24
(B) external biological characteristics that are ambiguous
25
resulting from having a 46,XX karyotype with virilization
26
or 46,XY karyotype with undervirilization.
27
(2) Services provided to a minor who has an abnormal sex
28
chromosome structure that has been diagnosed using genetic
29
testing by a physician licensed under IC 25-22.5.
30
(3) The treatment of any infection, injury, disease, or disorder
31
that has been caused by or exacerbated by the performance of
32
gender transition procedures.
33
(4) Any procedure undertaken because the individual suffers
34
from a physical disorder, physical injury, or physical illness
35
that would, as certified by a physician, place the individual in
36
imminent danger of death or impairment of major bodily
37
function unless surgery is performed.
38
Sec. 15. Public funds may not be directly or indirectly used,
39
granted, paid, or distributed to any entity, organization, or
40
individual that provides gender transition procedures to a minor.
41
Sec. 16. Health care services furnished in the following
42
situations may not include gender transition procedures to a
2023
IN 1231—LS 7276/DI 147
7
1
minor:
2
(1) By or in a health care facility owned by the state, a county,
3
or a municipality.
4
(2) By a physician or other practitioner employed by state,
5
county, or local government.
6
Sec. 17. (a) An individual, or the individual's parent or guardian
7
if the individual is a minor, who suffers harm as a result of a
8
gender transition procedure provided in violation of this chapter
9
may bring a cause of action against the health care professional
10
who provided the procedure.
11
(b) An action described in subsection (a) must be commenced
12
not later than fifteen (15) years after the individual becomes
13
eighteen (18) years of age.
14
(c) A court may award reasonable attorney's fees, litigation
15
expenses, and costs to a person who prevails in an action under
16
subsection (a).
17
SECTION 15. IC 27-2-28 IS ADDED TO THE INDIANA CODE
18
AS A NEW CHAPTER TO READ AS FOLLOWS [EFFECTIVE
19
JULY 1, 2023]:
20
Chapter 28. Gender Transition Procedures
21
Sec. 1. As used in this chapter, "coverage" means the right of an
22
individual to receive:
23
(1) health care services; or
24
(2) payment or reimbursement for health care services;
25
from a health carrier.
26
Sec. 2. As used in this section, "gender transition procedures"
27
has the meaning set forth in IC 16-35-12-6.
28
Sec. 3. (a) As used in this chapter, "health carrier" means an
29
entity:
30
(1) that is subject to this title and the administrative rules
31
adopted under this title; and
32
(2) that enters into a contract to:
33
(A) provide health care services;
34
(B) deliver health care services;
35
(C) arrange for health care services; or
36
(D) pay for or reimburse any of the costs of health care
37
services.
38
(b) The term includes the following:
39
(1) An insurer, as defined in IC 27-1-2-3(x), that issues a
40
policy of accident and sickness insurance, as defined in
41
IC 27-8-5-1(a).
42
(2) A health maintenance organization, as defined in
2023
IN 1231—LS 7276/DI 147
8
1
IC 27-13-1-19.
2
(3) An administrator (as defined in IC 27-1-25-1(a)) that is
3
licensed under IC 27-1-25.
4
(4) A state employee health plan offered under IC 5-10-8.
5
(5) A short term insurance plan (as defined by IC 27-8-5.9-3).
6
(6) Any other entity that provides a plan of health insurance,
7
health benefits, or health care services.
8
(c) The term does not include:
9
(1) an insurer that issues a policy of accident and sickness
10
insurance;
11
(2) a limited service health maintenance organization (as
12
defined in IC 27-13-34-4); or
13
(3) an administrator;
14
that only provides coverage for, or processes claims for, dental or
15
vision care services.
16
Sec. 4. (a) A health plan may not include coverage or
17
reimbursement for gender transition procedures for an individual
18
who is less than eighteen (18) years of age.
19
(b) A health plan is not required to provide coverage for gender
20
transition procedures.
21
SECTION 16. IC 34-18-1-1 IS AMENDED TO READ AS
22
FOLLOWS [EFFECTIVE JULY 1, 2023]: Sec. 1. This article does not
23
apply to:
24
(1) an act of malpractice that occurred before July 1, 1975; or
25
(2) an action brought under IC 16-35-12 (gender transition
26
procedures for minors).
2023
IN 1231—LS 7276/DI 147